TMC Innovation Factory Hosts Cohort 17 for its HealthTech Accelerator Bootcamp.
TMCi is eager to welcome 10 companies to Houston for final diligence for the HealthTech Accelerator program. These startups are tackling challenges ranging from heart failure to chronic respiratory disease and more. Leveraging both medical device and digital health solutions, these entrepreneurs will pursue insights, relationships, and community in Bootcamp. A subset of these teams will be selected for full program participation spanning into Spring 2024.
Each company will have the opportunity to build relationships with stakeholders from our member institutions and corporate partners while also refining their go-to-market strategy at the world’s largest medical campus, TMC.
Learn more about the companies joining TMCi Healthtech Accelerator Bootcamp:
Acorai is developing a first-of-its-kind, hand-held, scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide.
Aevice Health developed a connected care platform powered by the world’s smallest smart wearable stethoscope to support chronic respiratory disease patients through their continuum of care.
AirSeal developed a novel serum-based biomarker technology – circulating fatty acid synthase (cFAS) – that can diagnose cardiovascular and peripheral artery disease with high accuracy in both women and men.
Candlelit Care is a point-of-care digital platform focused on the prevention of perinatal mental and anxiety disorders (PMADs) among Black women and birthing parents.
Knowtex artificial intelligence-powered software writes medical documentation for you and assigns correct codes to ensure proper reimbursement.
NeuroBell is developing a novel medical device providing portable EEG monitoring with real-time & automated neonatal seizure alerts at the bedside.
OncoRes Medical is developing an intraoperative imaging technology to provide surgeons with real-time assessment of tissue microstructure.
Steradian Technologies’ RUMI is the first noninvasive, fully portable infectious disease diagnostic that costs the price of a latte. It uses novel photon-based detection to collect and diagnose infectious diseases in breath within 30 seconds.
Foxo serves as an interoperable tool designed to enhance clinical collaboration across the healthcare ecosystem. It enables secure, two-way communication with features such as video, voice, screen share, file sharing, and real-time messaging.
Thrive Health’s platform is a low-code framework for designing and delivering patient engagement solutions. Create tools that enable partners to close healthcare gaps quickly, strengthen care relationships, and improve patient experience and outcomes.
Update: Congratulations to the companies in Cohort 17
TMCi is eager to welcome eight companies to Houston for the HealthTech Accelerator program, where they will navigate through a six-month-long journey spanning into the Spring of 2024.
Follow along with each startup as we kick off our programming and hear from their founders, admire their achievements, and recognize their progress. We can’t wait to see the successes each company will bring to the forefront and future of healthcare in the upcoming accelerator months.
AcorAI (Stockholm, Sweden) is developing a first-of-its-kind, hand-held, scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide.
AirSeal (St. Louis, MO) developed a novel serum-based biomarker technology – circulating fatty acid synthase (cFAS) – that can diagnose cardiovascular and peripheral artery disease with high accuracy in both women and men.
Foxo (Brisbane, Australia) serves as an interoperable tool designed to enhance clinical collaboration across the healthcare ecosystem. It enables secure, two-way communication with features such as video, voice, screen sharing, file sharing, and real-time messaging.
Knowtex (San Francisco, CA) artificial intelligence-powered software writes medical documentation for you and assigns correct codes to ensure proper reimbursement.
NeuroBell (Cork, Ireland) is developing a novel medical device providing portable EEG monitoring with real-time & automated neonatal seizure alerts at the bedside.
Steradian Technologies’ (Houston, TX) RUMI is the first noninvasive, fully portable infectious disease diagnostic that costs the price of a latte. It uses novel photon-based detection to collect and diagnose infectious diseases in breath within 30 seconds.
TYBR (Houston, TX) has developed a flowable extracellular matrix hydrogel designed to protect healing tendons and ligaments from scarring and adhesions. This hydrogel supports an improved inflammation response, accelerates the body’s natural healing process, and enhances the quality of life for patients post-surgery.
OncoRes Medical (Australia) is developing an intraoperative imaging technology to provide surgeons with real-time assessment of tissue microstructure.